Literature DB >> 20597070

Drug therapy: tenofovir.

Anna S F Lok1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20597070     DOI： 10.1002/hep.23788

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

Review 1.  Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

Authors:  Ezequiel Ridruejo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

2.  Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA.

Authors:  L Gao; H N Trinh; J Li; M H Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2014-01-27       Impact factor: 8.171

Review 3.  An update on hepatitis B, D, and E viruses.

Authors:  Jennifer Price
Journal:  Top Antivir Med       Date:  2014-01

4.  Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature.

Authors:  Renato Pascale; Viola Guardigni; Lorenzo Badia; Francesca Volpato; Pierluigi Viale; Gabriella Verucchi
Journal:  Case Reports Hepatol       Date:  2017-11-15

Review 5.  Adverse effects of oral antiviral therapy in chronic hepatitis B.

Authors:  Bircan Kayaaslan; Rahmet Guner
Journal:  World J Hepatol       Date:  2017-02-18

6.  Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

Authors:  Manuel Rodríguez; Juan Manuel Pascasio; Enrique Fraga; Javier Fuentes; Martín Prieto; Gloria Sánchez-Antolín; José Luis Calleja; Esther Molina; María Luisa García-Buey; María Ángeles Blanco; Javier Salmerón; María Lucía Bonet; José Antonio Pons; José Manuel González; Miguel Ángel Casado; Francisco Jorquera
Journal:  World J Gastroenterol       Date:  2017-11-07       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.